NewsRx

Search our medical news database

Nutrition

New research studies confirm safety of chromium picolinate

Published in Genomics and Genetics Weekly, December 10th, 2004

Three new studies re-affirm the safety of the nutritional ingredient Chromax chromium picolinate, further validating a rapidly increasing body of peer-reviewed scientific research.

One of the 3 studies, presented at the 25th Annual Meeting of the American College of Toxicology (ACT) is a double-blind, placebo controlled trial of 110 patients. No significant adverse effects where found in the 70 clinically depressed patients receiving 400-600 mcg of chromium as chromium picolinate orally for up to 8 weeks.

Separately, new research from Purdue University, published in the International Journal of Sports Nutrition and Exercise Metabolism,...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Genomics and Genetics Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook